Li, Qimeng
Nemecz, Ákos http://orcid.org/0000-0002-1310-8964
Aymé, Gabriel http://orcid.org/0000-0002-0438-8095
Dejean de la Bâtie, Gabrielle
Prevost, Marie S. http://orcid.org/0000-0001-5621-3708
Pons, Stéphanie
Barilone, Nathalie http://orcid.org/0000-0003-0373-7262
Baachaoui, Rayen
Maskos, Uwe
Lafaye, Pierre http://orcid.org/0000-0002-5761-1342
Corringer, Pierre-Jean
Funding for this research was provided by:
H2020 European Research Council (788974)
Agence National de la Recherche (ANR-17-CE11-0030)
Institut National du Cancer
LanZhou Institute of Biological Products Co.
Centre National de la Recherche Scientifique
Institut Pasteur (PTR 03-17 Nicobinder)
Fondation pour la Recherche Médicale (FRM-Equipe)
Horizon 2020 Framework Programme (ERA-NET Neuron)
Article History
Received: 15 December 2022
Revised: 28 March 2023
Accepted: 7 April 2023
First Online: 25 May 2023
Declarations
:
: QL, ÁN, GA, PJC, PL, MP, NB are inventors of patent application US 63/383,099 that covers the VHH and therapeutic uses thereof.
: Not applicable.
: Not applicable.